Rocket Doctor AI (Treatment.com AI Inc.)

by Treatment.com AI Inc. (U.S. subsidiary of Rocket Doctor AI Inc.)  · Based in Canada →Transforming patient care through AI-powered clinical insights.
Emergency Medicine Family Medicine Internal Medicine

Contact for pricing

Overview

Treatment.com AI Inc., now a U.S. subsidiary of Rocket Doctor AI Inc., is a healthcare technology company focused on leveraging artificial intelligence to enhance patient care. The company aims to improve patient outcomes, provide more time for healthcare professionals to interact with patients, enhance medical education, reduce administrative burdens and costs, and mitigate healthcare fraud. Their core offering is the Global Library of Medicine (GLM), a proprietary and curated repository of diagnostic medical information. Unlike AI platforms relying solely on large language models, the GLM draws knowledge from a contributor pool of medical professionals and accredited clinical content, ensuring accuracy and trustworthiness through peer review. The GLM addresses over 1,000 diseases and 10,000+ symptoms and risk factors, providing step-by-step explanations, likelihoods associated with symptoms, and recommendations for lab tests, X-rays, and physician exams, with geographic awareness factored into diagnoses. Additionally, Treatment.com AI offers a Medical Education Suite (MES), underpinned by the GLM, which provides diverse cases, enables standardized evaluation of clinical skills, and streamlines exam creation and grading for schools, educators, and students.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered clinical insights
  • Proprietary Global Library of Medicine (GLM)
  • Differentiated from LLM-based AI
  • Curated and peer-reviewed medical content
  • Addresses over 1,000 diseases & 10,000+ symptoms
  • Provides explanations for diagnostic steps and likelihoods
  • Recommends lab tests, X-rays, and physician exams
  • Geographic awareness in diagnoses
  • Medical Education Suite (MES) for schools and students
  • Standardized evaluation of clinical skills

Use Cases

  • Improving patient outcomes through better healthcare decisions
  • Enhancing medical education and student learning
  • Reducing administrative time and costs for healthcare professionals
  • Mitigating fraud in healthcare systems
  • Providing clinical decision support for healthcare professionals
  • Streamlining exam creation and grading in medical schools

Details

Category Clinical Decision Support & Reference, Medical Education & Training
Pricing Contact for pricing
DeploymentCloud-based
Compliance
BAA AvailableUnknown AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Unknown AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Family Medicine, Internal Medicine

What the Web Says

Rocket Doctor AI (formerly Treatment.com AI Inc.) is a healthcare technology company that leverages AI, specifically its Global Library of Medicine (GLM), to enhance patient care and streamline healthcare processes. The company aims to provide accessible, high-quality virtual healthcare services, particularly for underserved populations in Canada and the US. They offer an AI-powered digital health platform and marketplace that supports physicians in running virtual practices and provides tools for patient triage, diagnosis, and treatment plans. Reviews indicate a mixed but generally positive sentiment, with many users appreciating the convenience and speed of service, while some highlight issues with communication and missed appointments.

Overall: Mixed

Strengths

  • Convenience and speed of service, often with same-day appointments and prescriptions.
  • Helpful and knowledgeable staff, with doctors often described as compassionate and thorough.
  • Valuable alternative to traditional clinics, especially for those without a primary care provider or with urgent needs.
  • Proprietary and accurate AI technology (Global Library of Medicine) validated by clinicians.
  • Ability to integrate with existing healthcare systems like EMRs and telehealth platforms.
  • Focus on serving underserved populations, including Medicaid patients in the US.

Limitations

  • Significant issues with communication and customer service, including long response times or no replies to inquiries.
  • Some customers reported doctors missing appointments or not being as attentive as expected.
  • Potential for short appointment times, which may not be suitable for larger or complex concerns.
  • Occasional issues with prescriptions not being sent through correctly or delays in receiving them.
  • Concerns about the service being unhelpful for more complex medical issues.
  • Some users felt rushed or not properly cared for by certain doctors.

Based on reviews from: Reddit, Trustpilot, Treatment.com AI Inc., YouTube, G2, Endpoints News, Doctronic

Last updated: 2026-06-24

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Rocket Doctor AI (Treatment.com AI Inc.)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

The Canadian Securities Exchange (CSE)
Rocket Doctor AI Subsidiary Treatment.com Secures Year 2 NIH Funding to Advance AI-Powered Family Health History Tool
Rocket Doctor AI's subsidiary, Treatment.com, received second-year funding from the National Institute on Minority Health and Health Disparities, part of the NIH, to develop an AI-powered family medical history tool. This funding extends support for the project through May 31, 2027, with a total award value of approximately $2 million.
2026-06
DoctorConnect
Best Healthcare AI API in 2026: Top Solutions Compared
Rocket Doctor AI (Treatment.com AI Inc.) is highlighted for its AI-driven clinical decision support and medical education APIs, particularly its Global Library of Medicine (GLM). The platform aims to provide scalable decision support and automate administrative tasks, though it does not disclose EHR integration numbers or a long-standing compliance record.
2026-04
The Canadian Securities Exchange (CSE)
Rocket Doctor AI Announces Strong Q1 Momentum Driven by U.S. Expansion, New Payer Contracts and Platform Growth
Rocket Doctor AI reported strong Q1 momentum, attributed to its expansion in the U.S., new payer contracts, and overall platform growth. This indicates a successful period of commercialization and increased market penetration.
2026-06
myMotherLode.com
AI Bridges Healthcare Divides While WHO Calls for Caution Amidst Rapid Advancements
Rocket Doctor AI, which rebranded in August 2025 after acquiring Rocket Doctor Inc., is noted for its clinician-centric AI development and proprietary Global Library of Medicine (GLM). The company's strategy focuses on integrating its GLM with a robust digital health platform to offer end-to-end solutions, particularly for Medicaid and Medicare patients.
2025-12
Nasdaq
Rocket Doctor AI Reports Strong Q3 Momentum Driven by U.S. Expansion, New Payer Contracts and Platform Growth
Rocket Doctor AI announced its financial results for Q3 2025, showing continued sequential organic revenue growth despite expected summer seasonality. The company also highlighted pivotal 'in-network' new payer agreements in the U.S., expanding its ability to serve over 13 million insured members across California, Maryland, and New York State.
2025-12
YouTube (McNallie Money)
Rocket Doctor AI: The $2M NIH Validation That Could Change Everything
This video discusses Rocket Doctor AI's U.S. subsidiary, Treatment.com, receiving a $2 million Phase 2 grant from the National Institute of Health in partnership with Rush River Research. The grant is for an AI-powered family health history tool, highlighting the competitive nature of such awards and the GLM's physician-built foundation.
2025-10
GuruFocus
Treatment.com AI Inc. to Rebrand as Rocket Doctor AI Inc., Aligning Business with Evolving Product Portfolio and Market Strategy
Treatment.com AI Inc. announced its rebranding to Rocket Doctor AI Inc., effective August 21, 2025, with the new ticker AIDR. This strategic move follows the acquisition of Rocket Doctor Inc. in April 2025, aiming to integrate their Global Library of Medicine with Rocket Doctor's digital health platform to enhance healthcare access.
2025-08
AIRDF (OTC Markets)
Rocket Doctor AI Reports First Revenues in Q2, 2025 Following Acquisition
Rocket Doctor AI Inc. (formerly Treatment.com AI Inc.) announced its Q2 2025 financial results, reporting its first significant revenue of $0.5 million, primarily driven by the acquisition of Rocket Doctor Inc. The acquisition expanded the platform to support over 300 clinicians and 600,000 patient visits.
2025-08

Videos

Product demos, reviews, and walkthroughs for Rocket Doctor AI (Treatment.com AI Inc.).

View all on YouTube

Frequently Asked Questions

Rocket Doctor AI is designed to integrate with existing EMR systems to streamline clinical decision support. It aims to provide a seamless experience by allowing physicians to access AI-powered insights directly within their current workflow, reducing the need to switch between multiple platforms.
Rocket Doctor AI's treatment recommendations are based on a comprehensive knowledge base derived from over 20,000 peer-reviewed articles, medical textbooks, and clinical guidelines. The platform utilizes advanced algorithms to ensure that its suggestions are evidence-based and clinically sound.
Rocket Doctor AI functions as a clinical decision support tool, meaning the ultimate responsibility for patient care and treatment decisions remains with the physician. The platform is designed to augment, not replace, physician judgment, and it emphasizes that physicians are accountable for their clinical choices.
Rocket Doctor AI prioritizes data privacy and patient confidentiality by adhering to strict regulatory standards like HIPAA. The platform employs robust encryption and security protocols to protect sensitive patient information, ensuring compliance with all applicable data protection laws.
Rocket Doctor AI offers various pricing models, including options for individual physicians and larger healthcare organizations. Specific details regarding costs and subscription tiers can be obtained by contacting Treatment.com AI Inc. directly for a personalized quote.
While Rocket Doctor AI is a powerful tool, it is not intended to replace human clinical judgment. Physicians should exercise caution and rely on their own expertise in complex or unusual cases, situations requiring nuanced patient communication, or when the AI's recommendations conflict with their professional assessment.
Rocket Doctor AI leverages its extensive knowledge base to provide support even for rare diseases or atypical presentations. However, in such cases, the system may flag the limited data availability, prompting the physician to exercise increased clinical discretion and potentially seek further consultation.

Related Tools

OCTA
OCTA
Clinical Decision Support & Reference
OCTA Flow is an AI-powered platform that assists ophthalmologists in analyzing Optical Coherence Tomography Angiography (OCTA) scans to enhance diagnostic accuracy and efficiency.
Elsevier
Elsevier
Clinical Decision Support & Reference
ClinicalKey AI is a clinical decision support tool that uses artificial intelligence to provide physicians with rapid access to evidence-based medical information.
EvidenceMD
EvidenceMD
Clinical Decision Support & Reference
EvidenceMD is an AI-powered clinical decision support platform that provides physicians with rapid access to current and relevant medical evidence for informed decision-making.
FAITH project
AI Agent
Clinical Decision Support & Reference
The FAITH project focuses on Federated Artificial Intelligence for Trusted Healthcare, aiming to develop secure and privacy-preserving AI solutions for healthcare, including potential applications for physician directories.
AI-based support system for skin cancer diagnostics
German Cancer Research Center (DKFZ)
Clinical Decision Support & Reference
Scientists at the German Cancer Research Center have developed an AI-based support system for skin cancer diagnostics that explains its decisions, increasing doctors' confidence in both the AI and their own diagnoses.
Prof. Valmed
Prof. Valmed - validated medical information GmbH
Clinical Decision Support & Reference
Prof. Valmed is Europe's first CE Class IIb certified AI-supported medical co-pilot, providing healthcare professionals with validated, evidence-based medical information through an innovative AI platform.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-06-23 | First Added: 2026-06-23
AI Tool Finder
AI-powered search. Results may not be comprehensive.